Drugs / BIRT 1696 BS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02254096 | May → Jul 2002 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIRT 1696 BS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02254096 ↗ |
| Route | Oral | “Single Rising Oral Doses of BIRT 1696 BS” NCT02254096 ↗ |